New UK Rare Disease Framework Seeks To Reduce ‘Diagnostic Odyssey’ For Patients
Executive Summary
England, Scotland, Wales and Northern Ireland will publish their respective action plans to deliver the aims of the UK’s new framework for rare diseases.
You may also be interested in...
New UK Rare Disease Framework Seeks Better Patient Access & More International Collaboration
England, Scotland, Wales and Northern Ireland will publish their respective action plans to deliver the aims of the UK’s new framework for rare diseases.
UK Conservatives Promise ‘Innovative Medicines Fund’ If Re-Elected
More money to pay for innovative new medicines, more cash and support for the life sciences sector, and Brexit by 31 January 2020 are among promises made in the Conservative Party’s election platform.
Kite Strikes CAR-T Access & Discount Deal For Tecartus In England
Health technology assessment body NICE wants Kite to collect more evidence to prove that Tecartus can cure relapsed or refractory mantle cell lymphoma. But in the meantime, it says the CAR-T therapy should be made available on the National Health Service, making UK patients among the first in the world to be offered access to the treatment.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: